Verrica Pharmaceuticals Inc. (VRCA) Earning

NASDAQ Currency in USD Disclaimer

$0.70

north_east $0.02 (3.5%)
Day's range
$0.65
Day's range
$0.74

Verrica Pharmaceuticals Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.61 -$0.30 -$0.45
Q2 2024 1 -$0.57 -$0.28 -$0.41
Q3 2024 1 -$0.51 -$0.26 -$0.38
Q4 2024 3 -$0.41 -$0.20 -$0.30
Q1 2025 1 -$0.27 -$0.14 -$0.20
Q2 2025 1 -$0.22 -$0.11 -$0.16
Q3 2025 1 -$0.19 -$0.10 -$0.14
Q4 2025 1 -$0.17 -$0.09 -$0.13

Verrica Pharmaceuticals Inc. Earnings Date And Information

Verrica Pharmaceuticals Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.49 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37 by $0.12. The company had revenue of -1,781,000 for the quarter and had revenue of 5.12 M for the year. Verrica Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.48 diluted earnings per share) and currently has a price-to-earnings ratio of -0.38. Verrica Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Verrica Pharmaceuticals Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/04/2024 Q3 2024 -$0.49 $5.26 M $-1,781,000
08/14/2024 Q2 2024 -$0.43 -$0.37 0.06 $4.58 M $5.18 M
05/13/2024 Q1 2024 -$0.54 -$0.44 0.1 $3.83 M
02/29/2024 Q4 2023 -$0.47 -$0.53 -0.06 $1.99 M
11/09/2023 Q3 2023 -$0.22 -$0.54 -0.32 $454,068 $2.92 M
08/08/2023 Q2 2023 -$0.22 -$0.24 -0.02 $57,600 $182,000
05/09/2023 Q1 2023 -$0.20 -$0.14 0.06 $37,000
03/06/2023 Q4 2022 -$0.20 -$0.14 0.06 $68,000
11/07/2022 Q3 2022 -$0.11 $0.00 0.11 $4.33 M $8.32 M
08/11/2022 Q2 2022 -$0.32 -$0.41 -0.09 $312,500 $214,000
05/09/2022 Q1 2022 -$0.54 -$0.35 0.19 $431,000
03/02/2022 Q4 2021 -$0.48 -$0.35 0.13 $-12,000,000
11/12/2021 Q3 2021 -$0.49 -$0.47 0.02 $0
08/10/2021 Q2 2021 -$0.41 -$0.43 -0.02 $200,000 $0
05/07/2021 Q1 2021 -$0.35 -$0.04 0.31 $12.00 M
03/17/2021 Q4 2020 -$0.52 $0
11/09/2020 Q3 2020 -$0.46 -$0.42 0.04 $0
08/05/2020 Q2 2020 -$0.45 -$0.38 0.07 $0
05/07/2020 Q1 2020 -$0.39 -$0.39 0 $0
03/13/2020 Q4 2019 -$0.30 -$0.31 -0.01 $0
 

Verrica Pharmaceuticals Inc. Earnings: FAQ's

When is Verrica Pharmaceuticals Inc.'s earnings date?

Verrica Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

How can I listen to Verrica Pharmaceuticals Inc.'s earnings conference call?

The conference call for Verrica Pharmaceuticals Inc.'s latest earnings report can be listened to online.

How can I read Verrica Pharmaceuticals Inc.'s conference call transcript?

The conference call transcript for Verrica Pharmaceuticals Inc.'s latest earnings report can be read online.

How much revenue does Verrica Pharmaceuticals Inc. generate each year?

Verrica Pharmaceuticals Inc. (:VRCA) has a recorded annual revenue of $5.12 M.

How much profit does Verrica Pharmaceuticals Inc. generate each year?

Verrica Pharmaceuticals Inc. (:VRCA) has a recorded net income of $5.12 M. Verrica Pharmaceuticals Inc. has generated $-1.48 earnings per share over the last four quarters.

What is Verrica Pharmaceuticals Inc.'s price-to-earnings ratio?

Verrica Pharmaceuticals Inc. (:VRCA) has a price-to-earnings ratio of -0.38 and price/earnings-to-growth ratio is -0.14.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED